"Enteral syringe market to exhibit dynamic growth during the forecast period"

The global enteral syringe market is increasing proficiently, expected to grow at a CAGR of 5.3%. Globally, the rising commonness of chronic illness and numerous lifestyle disorders will drive the overall growth of the market. Enteral syringes deliver nutritional therapy or medications to different age groups including pediatrics, and adult patients. Enteral syringes are available in different sizes ranging from 1ml to 60 ml and are generally used for patients in hospitals/clinics, and home care. Globally increasing neonatal admissions, gastrointestinal diseases, cancer, malnutrition and overall management of treatment for various diseases are major factors driving the overall growth of the enteral syringes market.

"Single-use enteral syringes expected to register higher growth by the end of 2033"

New ENFit ISO standard single use enteral syringes are gaining traction, developed to deliver enteral feeds, liquid medications or nutrition safely to neonatal, and adult patients. Enteral syringes (single use/reusable) now comes with ENFit compatibility with a standard purple color, differentiating from other IV feeding systems. Low dose syringes also come with female ENFit connection. Top manufacturers now comply with ENFit standard design (new ISO80369 standard) are receiving FDA clearance. The safety systems are also friendly with all other enteral feeding devices used within the clinics/hospital and home care settings for smooth transition.

Oncology segment to witness a significant CAGR

Increasing prevalence of cancer, chronic diseases, and growing number of hospital admissions for various lifestyle diseases in the neonatal as well as adult population will enhance the growth of the market. In 2020, as per the statistics by International Agency for Research on Cancer (WHO), more than 18 million new cases were registered globally for cancer. Moreover, increasing admissions in the NICU segment on a global scale will drive the growth globally. Enhanced applications for enteral delivery, medicines, and nutritional content in the neonatal and paediatric segment will further spur revenue growth during the forecast period.

"Increased research and development with strong product pipelines in the developed regions"

Major players in the enteral syringe market are Cardinal Health Inc., Merit Medical Systems Inc., B. Braun Melsungen AG, Baxter International, Inc., Terumo Corporation, Vygon S.A., Koninklijke Philips N.V., Retractable Technologies Inc., Medline Industries Inc., Gerresheimer AG, Abbott Laboratories Inc., Kentec Medical, Inc., Miktell Ltd., Thermo Fischer, Inc. and others. Novel product launches with higher patient safety and compatibility (for all age groups), partnerships, new technology expansion in developing nations and improved R&D on enteral syringes will further drive the overall market growth. For e.g. In Aug 2016, NeoMed. Inc. and Medtronic plc received the U.S FDA 510(k) clearance for low dose tip ENFit syringes. FDA 510(k) clearance permits both techniques, enteral and direct oral administration.

Historical & Forecast Period

This study report represents analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Enteral Syringes market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Enteral Syringes market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Enteral Syringes market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2033.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Enteral Syringes market?
• Which is the largest regional market for Enteral Syringes market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Enteral Syringes market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Enteral Syringes market worldwide?